Intercytex Group plc announced that it is part of consortia that have been selected to establish the United States' Armed Forces Institute of Regenerative Medicine (AFIRM), supported by a foundation grant from the US Government totalling $85 million. The purpose of AFIRM is to use the scien ... more
To use all functions of this page, please activate cookies in your browser.
